Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia

Keyphrases

• COVID-19 100%
• Vaccination 100%
• Antibody Response 100%
• Chronic Lymphocytic Leukemia 100%
• Healthy Donors 75%
• Specific Antibodies 50%
• Anti-spike Antibody 50%
• Blood Samples 25%
• B-CLL 25%
• Multivariate Analysis 25%
• Immunosuppression 25%
• Titre 25%
• Current Treatment 25%
• Antibody Titre 25%
• Venipuncture 25%
• Extended Interval 25%
• Severe Infection 25%
• Clinical Risk 25%
• Vaccination Strategy 25%
• Work Support 25%
• Dried Blood Spot on Filter Paper 25%
• Booster Vaccine 25%
• SARS-CoV-2 Infection 25%
• ChAdOx1 25%
• COVID-19 Vaccine 25%
• BNT162b2 Vaccine 25%
• IgA Deficiency 25%
• BTK Inhibitor 25%

Medicine and Dentistry

• Antibody Response 100%
• B-Cell Chronic Lymphocytic Leukemia 100%
• Infection 33%
• Immunosuppressive Treatment 16%
• Multivariate Analysis 16%
• Dried Blood Spot 16%
• Vein Puncture 16%
• Immunoglobulin A Deficiency 16%
• Booster Dose 16%
• Severe Acute Respiratory Syndrome Coronavirus 2 16%
• mRNA Vaccine 16%

Immunology and Microbiology

• Antibody Response 100%
• Spike 33%
• B Cell 16%
• Immunosuppression 16%
• Antibody Titer 16%
• Booster Dose 16%
• Immunoglobulin A Deficiency 16%
• Severe Acute Respiratory Syndrome Coronavirus 2 16%